Pathogenetic treatment of non-specific back pain
https://doi.org/10.21518/2079-701X-2018-9-25-28
Abstract
Back pain is one of the most common reason for all physician visits, which makes the problem of rational therapy especially urgent. Non-specific dorsalgia is the most common in clinical practice, that is subdivided into acute, sub-acute or chronic. Modern guidelines for the treatment of acute and chronic non-specific back pain offer primarily the use of non-drug methods – cognitive-behavioural therapy and therapeutic gymnastics, and if they are ineffective – rational pharmacotherapy, taking into account the comorbid pathology in patients. Non-steroidal anti-inflammatory drugs, in particular Dexalgin, are the drugs of choice for the management of pain syndrome.
About the Authors
O. E. Zinovieva
I.M.Sechenov First Moscow State Medical University FGAOU VO of the Ministry of Health of Russia (Sechenov University)
Russian Federation
Russian Federation
A. N. Barinov
Interregional Association for Palliative and Interventional Medicine Specialists (MASPIM)
Russian Federation
Russian Federation
References
1. Isaikin AI, Kuznetsov IV, Kavelina AV. Nonspecific lumbalgia: causes, clinical picture, diagnosis, treatment. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2015, 7 (4): 101-109.
2. Karateev AE, Nasonov EL, Yakhno NN, et al. Clinical guidelines: rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice. Sovremennaya Revmatologiya, 2015, 1: 4-23.
3. Parfenov VA, Gerasimova ON Management of patients with back pain in outpatient practice. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2010, 2 (4): 65-71.
4. Parfenov VA. Causes, diagnosis and treatment of lower back pain. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2009, 1: 19-22.
5. Parfenov VA. Diagnosis and treatment of acute lower back pain. RMJ, 2007, 15 (6): 507-510.
6. Podchufarova EV, Yakhno NN. Back pain. Moscow: GEOTAR-Media, 2013. 368 p.
7. Podchufarova EV. Back pain treatment. Nevrologiya, Neyropsihiatriya, Psikhosomatika, 2009, 2: 29-36.
8. Podchufarova EV. Mechanisms in the development and treatment of back pain. Sovremennaya Terapiya v Psihiatrii I Nevrologii, 2012, 3: 47-54.
9. Beltran J, Martin-Mola E, Figuero M et al. Comparison of Dexketoprofen Trometamol and Ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharm, 1998, 38: 74–80.
10. Clark DW, Layton D, Shakir SA. Do some inhibitors of COX-2 increase the risk of thromboembolic events? Linking pharmacology with pharmacoepidemiology. Drug Saf, 2004, 27(7): 427-56.
11. Goubert D, Van Oosterwijck J, Mira Meeus M, Danneels L. Structural Changes of Lumbar Muscles in Non-Specific Low Back Pain. Pain Physician, 2016, 19: E985-E1000.
12. Hayden JA, van Tulder MW, Malmivaara A et al. Exercise therapy for treatment of non-specific low back pain. Cochrane database Syst Rev, 2005, Jul 20, 3: CD000335.
13. Kuritzky L, Samraj GP. Nonsteroidal anti-inflammatory drugs in the treatment of low back pain. J Pain Res, 2012, 5: 579–590.
14. Rossignol M, Arsenault B, Dionne C et al. Clinic on low-back pain in interdisciplinary practice (clip) guidelines. 2007. http://www.santpub-mtl.qc.ca/clip.
15. van Tulder M, Becker А, Bekkering T et al. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J, 2006, 15(Suppl. 2): 169-91.
Review
For citations:
Zinovieva OE, Barinov AN. Pathogenetic treatment of non-specific back pain. Meditsinskiy sovet = Medical Council. 2018;(9):25-28. (In Russ.) https://doi.org/10.21518/2079-701X-2018-9-25-28
Views:
817
Email this article 